SK361292A3 - Piperidylmethyl-substituted chroman derivatives, process for producing them, their use and pharmaceutical composition containg same - Google Patents

Piperidylmethyl-substituted chroman derivatives, process for producing them, their use and pharmaceutical composition containg same Download PDF

Info

Publication number
SK361292A3
SK361292A3 SK3612-92A SK361292A SK361292A3 SK 361292 A3 SK361292 A3 SK 361292A3 SK 361292 A SK361292 A SK 361292A SK 361292 A3 SK361292 A3 SK 361292A3
Authority
SK
Slovakia
Prior art keywords
group
carbon atoms
straight
branched alkyl
substituted
Prior art date
Application number
SK3612-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK278557B6 (en
Inventor
Hans-Georg Heine
Bodo Junge
Peter-Rudolf Seidel
Rudolf Schohe-Loop
Thomas Glaser
Vry Jean Marie V De
Wolfgang Dompert
Henning Sommermeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK278557B6 publication Critical patent/SK278557B6/sk
Publication of SK361292A3 publication Critical patent/SK361292A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK3612-92A 1991-12-09 1992-12-09 Piperidylmethyl-substituted chroman derivatives, process for producing them, their use and pharmaceutical composition containg same SK361292A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140542A DE4140542A1 (de) 1991-12-09 1991-12-09 Piperdylmethyl substituierte chormanderivate

Publications (2)

Publication Number Publication Date
SK278557B6 SK278557B6 (en) 1997-09-10
SK361292A3 true SK361292A3 (en) 1997-09-10

Family

ID=6446620

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3612-92A SK361292A3 (en) 1991-12-09 1992-12-09 Piperidylmethyl-substituted chroman derivatives, process for producing them, their use and pharmaceutical composition containg same

Country Status (22)

Country Link
US (1) US5326771A (enExample)
EP (1) EP0546389B1 (enExample)
JP (1) JP3162523B2 (enExample)
AT (1) ATE136896T1 (enExample)
AU (1) AU649901B2 (enExample)
CA (1) CA2084541A1 (enExample)
CZ (1) CZ281714B6 (enExample)
DE (2) DE4140542A1 (enExample)
DK (1) DK0546389T3 (enExample)
ES (1) ES2087407T3 (enExample)
FI (1) FI925550L (enExample)
GR (1) GR3019774T3 (enExample)
HU (2) HUT65525A (enExample)
IL (1) IL104005A0 (enExample)
MX (1) MX9206816A (enExample)
MY (1) MY130107A (enExample)
NO (1) NO303285B1 (enExample)
NZ (1) NZ245380A (enExample)
RU (1) RU2102392C1 (enExample)
SK (1) SK361292A3 (enExample)
TW (1) TW282468B (enExample)
ZA (1) ZA929497B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
CA2220649C (en) 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
EP0846683B1 (en) * 1996-12-03 2001-09-19 F. Hoffmann-La Roche Ag 4-Hydroxy-piperidine derivatives
SE9902765D0 (sv) * 1999-07-21 1999-07-21 Astra Pharma Prod Novel compounds
NZ535574A (en) 2001-01-16 2006-07-28 Astrazeneca Ab Therapeutic heterocyclic compounds
CA2434015A1 (en) * 2001-01-16 2002-07-18 Astrazeneca Ab Therapeutic chroman compounds
MXPA03006268A (es) 2001-01-16 2003-09-22 Astrazeneca Ab Compuestos terapeuticos de cromano.
EP1445324A4 (en) * 2001-11-09 2005-02-16 Kaneka Corp PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMAN DERIVATIVE AND INTERMEDIATE PRODUCT
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
WO2005033092A1 (en) 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. Chroman derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826835A (en) * 1971-01-08 1974-07-30 Ciba Geigy Corp 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics
US4016281A (en) * 1975-02-22 1977-04-05 Merck Patent Gesellschaft Mit Beschrankter Haftung Tetralone and indanone compounds
DE2950135A1 (de) * 1979-12-13 1981-06-19 Merck Patent Gmbh, 6100 Darmstadt Basischer aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
GB8515389D0 (en) * 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
EP0285356A3 (en) * 1987-03-30 1989-05-31 Smithkline Beecham Corporation Dopamine-beta-hydroxylase inhibitors
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
GB8823980D0 (en) * 1988-10-13 1988-11-23 Glaxo Group Ltd Chemical compounds
FR2642068B1 (fr) * 1989-01-20 1991-04-12 Rhone Poulenc Sante Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane

Also Published As

Publication number Publication date
ZA929497B (en) 1993-06-10
JP3162523B2 (ja) 2001-05-08
NO303285B1 (no) 1998-06-22
CZ361292A3 (en) 1993-08-11
RU2102392C1 (ru) 1998-01-20
TW282468B (enExample) 1996-08-01
AU649901B2 (en) 1994-06-02
GR3019774T3 (en) 1996-07-31
SK278557B6 (en) 1997-09-10
NZ245380A (en) 1994-06-27
NO924547L (no) 1993-06-10
MY130107A (en) 2007-06-29
ATE136896T1 (de) 1996-05-15
MX9206816A (es) 1993-07-01
NO924547D0 (no) 1992-11-25
AU2993692A (en) 1993-06-10
ES2087407T3 (es) 1996-07-16
US5326771A (en) 1994-07-05
FI925550A0 (fi) 1992-12-07
IL104005A0 (en) 1993-05-13
JPH05262766A (ja) 1993-10-12
DE59206036D1 (de) 1996-05-23
DE4140542A1 (de) 1993-06-17
CZ281714B6 (cs) 1996-12-11
HU9203896D0 (en) 1993-03-29
EP0546389B1 (de) 1996-04-17
EP0546389A1 (de) 1993-06-16
DK0546389T3 (da) 1996-08-12
FI925550A7 (fi) 1993-06-10
FI925550L (fi) 1993-06-10
HUT65525A (en) 1994-06-28
CA2084541A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
US5545643A (en) Azaheterocyclylmethyl-chromans
EP1260512B1 (en) Novel cyclic amide derivatives
JPWO2001064670A1 (ja) 新規環状アミド誘導体
KR20180119663A (ko) 항박테리아 화합물 및 그의 용도
SK278557B6 (en) Piperidylmethyl substituted derivatives of chroman, producing method and use thereof, and pharmaceutical composition containing same
EP2616460B1 (en) Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
HUT54151A (en) Process fopr producing new (r)-(-)-3-quinuclidinone derivatives and pharmaceutical compositions comprising such compounds
CZ322492A3 (en) Triazaspirodecanone-methyl chromans
CN108117551A (zh) 取代(1H-吡唑[3,4-b]吡啶)脲类化合物及其抗肿瘤用途
HK1185878B (en) Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine